PhD: Targeted Alpha Therapy for GBM — Intl Secondments

Université d'Angers; France; Sur place; EUR 67 000 - 70 000; Plein temps

Avantages offerts par ce poste

Secondments abroad

MSCA-DN programme salary

Résumé du poste

Université d'Angers invites applications for a 36-month PhD position under the MSCA Doctoral Network INNOVARTBRAIN, Team 5 GLIAD. The successful candidate will study alpha-therapy approaches for glioblastoma, using preclinical models and advanced molecular analyses.

The project involves international secondments (INEM Paris, MUW Vienna) and cross-disciplinary training across cancer biology, radiopharmacy, and imaging in a vibrant European research network.

Qualifications

• Master’s degree in neuroscience, neuro-oncology, cancer biology, molecular biology, biomedical sciences, radiopharmacy, or related field.

Responsabilités

• Investigate targeted alpha therapy as locoregional treatment for glioblastoma.
• Perform preclinical experiments, imaging, histology and molecular analyses.
• Collaborate with international partner sites and manage data interpretation.

Connaissances

Neuroscience

Neuro-oncology

Cancer biology

Molecular biology

Bioinformatics

Formation

Master's degree or equivalent

Outils

Radiopharmacy

In vivo imaging

Single-cell analysis

Description du poste

Université d'Angers invites applications for a 36-month PhD position under the MSCA Doctoral Network INNOVARTBRAIN, Team 5 GLIAD. The successful candidate will study alpha-therapy approaches for glioblastoma, using preclinical models and advanced molecular analyses.

The project involves international secondments (INEM Paris, MUW Vienna) and cross-disciplinary training across cancer biology, radiopharmacy, and imaging in a vibrant European research network.